Vendor COA profile

Koi Peptides

Public PDF COAs on koipeptides.com/coa/.

Compare COA track records Claim / manage this brand Upload a COA for this brand

65Trust

Mixed signals

This trust score is solid because complete reviews average legitimacy 84, partial core panel coverage (67%), and 8 COAs carry soft notes. To improve: cover identity, purity, and endotoxin on each lot and grow the public sample beyond a handful of COAs.

Public COAs audited

Core panel coverage

67%

Identity, purity, endotoxin (lot-aware)

Only 67% lot-aware core coverage across identity, purity, and endotoxin. Prioritize publishing the three core panels for every active lot.

High-concern reports

Likely fake / reused only · 8 with soft notes

Soft notes do not count as high concern, but clearing them still lifts avg legitimacy.

Avg legitimacy (public)

Among complete COA reviews

Complete reviews average 84, and 8 still carry soft notes. Publish full identity/purity/endotoxin sets per lot and make lab verification links easy to check.

Brand owners

Manage this brand's reputation

Claim or update the directory listing, upload certificates of analysis tied to Koi Peptides in the PeptIQ app, and grow this public trust score as moderated COAs are approved. Nothing goes live until review.

Claim / list brand profile Upload COAs in the app COA market rankings

Recent public COA audits

Each report links to a full evidence-backed breakdown.

Retatrutide · Retatrutide 20mg
Sep 5, 2026 · Vendor trust 65 · Core panels 67% · Doc 88
Mostly consistent, with concerns
KPV
Sep 5, 2026 · Vendor trust 65 · Core panels 67% · Doc 72
Mostly consistent, with concerns
SS-31
Sep 5, 2026 · Vendor trust 65 · Core panels 67% · Doc 88
Mostly consistent, with concerns
Tesamorelin · Tesamorelin 10mg
Sep 5, 2026 · Vendor trust 65 · Core panels 67% · Doc 72
Mostly consistent, with concerns
KLOW 50/10/10/10mg · GHK-Cu
Sep 5, 2026 · Vendor trust 65 · Core panels 67% · Doc 88
Mostly consistent, with concerns
GHK-Cu · GHK-CU 100mg
Sep 5, 2026 · Vendor trust 65 · Core panels 67% · Doc 88
Mostly consistent, with concerns
Thymosin Beta-4 · TB-500
Sep 5, 2026 · Vendor trust 65 · Core panels 67% · Doc 88
Mostly consistent, with concerns
BPC-157
Sep 5, 2026 · Vendor trust 65 · Core panels 67% · Doc 88
Mostly consistent, with concerns

Embed this badge

Embed this badge on your site — links to your PeptIQ brand audit page.

<a href="https://peptiq.io/brands/koi-peptides"><img src="https://peptiq.io/api/coa/badge/koi-peptides" width="240" height="48" alt="Verified by PeptIQ COA auditing" /></a>

PeptIQ COA reports analyze document content and publicly verifiable lab signals. They are educational and not a guarantee of product quality, legality, or safety. Always consult a qualified professional before making health decisions. We never publish purchase prices, shipping details, or uploader identity.